World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
28628
World Ranking
2635
National Ranking
1255

Todd A. Fehniger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Todd A. Fehniger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 299 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Todd A. Fehniger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Todd A. Fehniger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Todd A. Fehniger is affiliated with Washington University in St. Louis, United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with extensive work in Immunology, Oncology, Molecular Biology, Pathology and Forensic Medicine, and Hematology. The main topics of their research include Immune Cell Function and Interaction, CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Immune cells in cancer, and Monoclonal and Polyclonal Antibodies Research.

Fehniger has contributed to a number of scientific publications, with recent notable papers including:

  • CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas, 2020, Blood
  • Allogeneic natural killer cell therapy, 2022, Blood
  • Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant, 2021, Blood
  • Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies, 2021, Clinical Cancer Research
  • Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia, 2020, Cancer Discovery

Frequent co-authors who have collaborated extensively with Fehniger include:

  • Melissa M. Berrien-Elliott
  • Amanda F. Cashen
  • David A. Russler-Germain
  • Michelle Becker-Hapak
  • Pamela Wong

Fehniger's research contributions have often appeared in leading publication venues. These include Blood, bioRxiv (Cold Spring Harbor Laboratory), The Journal of Immunology, European Journal of Immunology, and Clinical Lymphoma Myeloma & Leukemia. The majority of their published work can be found in Blood, with 28 contributions.

Best Publications

  • The biology of human natural killer-cell subsets.

    Megan A Cooper;Todd A Fehniger;Michael A Caligiuri

  • Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

    Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen

  • Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance

    Xuefang Cao;Sheng F. Cai;Todd A. Fehniger;Jiling Song

  • Interleukin 15: biology and relevance to human disease

    Todd A. Fehniger;Michael A. Caligiuri

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Mübeccel Akdis

  • CD56bright natural killer cells are present in human lymph nodes and are activated by T cell–derived IL-2: a potential new link between adaptive and innate immunity

    Todd A Fehniger;Megan A Cooper;Gerard J Nuovo;Marina Cella

  • Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune Response

    Todd A. Fehniger;Manisha H. Shah;Matthew J. Turner;Jeffrey B. VanDeusen

  • Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

    Rizwan Romee;Maximillian Rosario;Melissa M. Berrien-Elliott;Julia A. Wagner

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    Andrea Cossarizza;Hyun Dong Chang;Andreas Radbruch;Andreas Acs

  • TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    John S. Welch;Allegra A. Petti;Christopher A. Miller;Catrina C. Fronick

  • Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

    Sherif S. Farag;Todd A. Fehniger;Todd A. Fehniger;Loredana Ruggeri;Loredana Ruggeri;Andrea Velardi;Andrea Velardi

  • Cytokine activation induces human memory-like NK cells.

    Rizwan Romee;Stephanie E. Schneider;Jeffrey W. Leong;Julie M. Chase

  • NK cell and DC interactions.

    Megan A. Cooper;Todd A. Fehniger;Anja Fuchs;Marco Colonna

  • In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.

    Megan A. Cooper;Jennifer E. Bush;Todd A. Fehniger;Jeffrey B. VanDeusen

  • Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs.

    Todd A. Fehniger;Sheng F. Cai;Xuefang Cao;Andrew J. Bredemeyer

  • A potential role for interleukin-15 in the regulation of human natural killer cell survival.

    W E Carson;T A Fehniger;S Haldar;K Eckhert

  • Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells

    Todd A. Fehniger;Kazuhiro Suzuki;Anand Ponnappan;Jeffrey B. VanDeusen

  • First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

    Rizwan Romee;Sarah Cooley;Melissa M. Berrien-Elliott;Peter Westervelt

  • Interleukin-2 and interleukin-15: immunotherapy for cancer.

    Todd A Fehniger;Megan A Cooper;Michael A Caligiuri

  • Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets.

    Margaret Frey;Nalini B. Packianathan;Todd A. Fehniger;Mary E. Ross

Frequent Co-Authors

John F. DiPersio
John F. DiPersio Washington University in St. Louis
Michael A. Caligiuri
Michael A. Caligiuri City Of Hope National Medical Center
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis
Peter Westervelt
Peter Westervelt Brown University
Ravi Vij
Ravi Vij Washington University in St. Louis
Megan A. Cooper
Megan A. Cooper Washington University in St. Louis
Timothy J. Ley
Timothy J. Ley Washington University in St. Louis
Obi L. Griffith
Obi L. Griffith Washington University in St. Louis
Malachi Griffith
Malachi Griffith Washington University in St. Louis
Elaine R. Mardis
Elaine R. Mardis The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related nursing degrees and certifications can open diverse career opportunities in healthcare and research. Many professionals consider accelerated paths to enter the field swiftly while maintaining quality education standards.

One popular route is enrolling in an accelerated nurse practitioner program. These programs are designed for individuals looking to advance quickly and become licensed nurse practitioners with a strong clinical background related to immunological care.

If you don’t have a nursing background, online options like online BSN programs for non nurses provide a flexible way to enter the nursing profession. These programs accommodate students from different academic experiences aiming to impact patient care and immunology research.

For those seeking an accessible entry point, some of the easiest ABSN programs to get into offer more lenient admission requirements while still delivering comprehensive nursing instruction relevant to immunology careers.

Additionally, gaining an acute care NP certification can specialize your expertise, allowing you to handle complex immunological cases in critical care settings and expand your professional horizons.

Best Scientists Citing Todd A. Fehniger

Trending Scientists

Recently Published Articles